Nina Capital's third fund backs technology-led healthcare companies across clinical innovation, healthcare infrastructure, care pathways and health data. Its first close was reported at €50m on 12 Feb 2025. The mandate covers Europe, North America, Israel and Australia. The stated stage focus is Pre-Seed, Seed, and Series A, with emphasis on Healthtech, Digital Health, and Medical Devices.
At a glance
Related tracked funds
Source and review
This fund record was manually reviewed on by the EverythingVC editorial team under our research methodology.
The capital figure reflects commitments reported by the cited source. It is not an estimate of remaining dry powder or current fundraising availability.
- Fund announcement: EU-Startups first-close report